How to Generate Legal & Mass Tort Leads With Video Ads (That Actually Convert)

By the AdsBabe team · Jan 31, 2026 · Updated Jul 22, 2026

Mass tort lead gen is one of the highest-CPL verticals in paid media - and one of the most unforgiving. A bad hook kills response. A compliance slip kills your account. And if your intake funnel leaks, the economics fall apart fast.

This guide is for affiliates, lead-gen operators, and law firm media buyers who want to run profitable video ad campaigns for mass tort cases. We cover the full workflow: hook writing, compliant copy, funnel structure, platform choices, and what to outsource.

How to Generate Legal & Mass Tort Leads With Video Ads: Step-by-Step

1. Pick one active case to start. Hair relaxer, AFFF, Depo-Provera, and Roundup are all active MDLs as of mid-2026. Do not scatter across five cases at launch. One case, one audience, one funnel.
2. Define the self-ID audience. Who used the product? When? What injury did they get? Write that out in one sentence: "Women 40-65 who used hair relaxers regularly before 2021 and were diagnosed with uterine cancer." That sentence IS your audience and your hook.
3. Write a self-ID callout hook. Open the video with the callout. Name the product, name the injury, name the timeframe. "Attention: if you used [product] for more than [X years] and were diagnosed with [injury], cases are being reviewed right now." No intro fluff.
4. Add the credibility layer. Back up the callout with a real evidence anchor - a study, a court MDL count, internal documents. "A 2022 NIH study found a 2.55x higher risk of uterine cancer in regular hair relaxer users." You can cite this. Do not invent numbers.
5. Deliver the no-risk offer. Contingency fee is your conversion mechanism. "You pay nothing unless you win. Free case review. No upfront costs." Say it plainly - most claimants do not know how contingency works.
6. Drive to an educational pre-lander, not a raw form. The pre-lander does the qualification work. It explains the case, lists eligibility criteria, and builds trust before the form. A news-framing style ("What You Should Know About the Hair Relaxer Lawsuit") works and carries less platform risk than hard news-jacking.
7. Collect first-party, one-to-one consented leads. Post-2024 FCC rules make shared leads legally risky. Your form must name the specific buyer at consent time. "By submitting this form, I consent to be contacted by [Firm Name]." This is not optional.
8. Pass qualified leads to intake immediately. Speed-to-contact is the #1 CPR (cost per retained client) variable. A lead called within 5 minutes converts at 2-3x a lead called the next day. Automate the handoff.
9. Test 3-5 hooks per case before scaling. Self-ID callouts, angry-lawyer angle, empathy/validation angle, science-first angle, deadline urgency - run small budgets ($20-50/day) on each, let CPL tell you which angle scales.
10. Add compliant disclosures to every creative. "Advertising material. Not legal advice. Past results do not guarantee future outcomes." On video, on-screen text at opening or closing. On statics, in the image or caption. Non-negotiable.

Hook Swipe File: 10 Copy-Paste Video Ad Openers

These are the 10 highest-leverage opening lines for mass tort video ads. Swap the brackets for your case. Keep them exactly this direct - no "Hi, I'm..." warmup.

Script Template: 60-Second Mass Tort Video Ad

Niche-Specific Angles and Compliance Notes by Case Type

Each active tort has its own audience, platform, and compliance profile. Here is what matters for each.

Hair Relaxer / Uterine Cancer

Audience: Black women 35-65 who used chemical relaxers before 2021. Diagnosis window matters - most cases require a uterine cancer or endometrial cancer diagnosis. NIH study citation is your credibility anchor. Platform: Meta runs this fine as of mid-2026. CPL runs $50-120 currently, expected to rise after the first bellwether trial. Tone: validation-first. "You're not alone in this."

AFFF Firefighting Foam / PFAS Cancers

Audience: Career and volunteer firefighters, military fire crews, 45-70, predominantly male. "Forever chemicals" is the consumer-friendly term for PFAS - use it. Eligible cancers are specific (kidney, testicular, thyroid, non-Hodgkin's lymphoma, bladder). CPL is $75-200. Tone: respect-forward, blue-collar. "You protected others. Now fight for yourself." Platform: Meta handles this well. YouTube adds scale for long-form education.

Depo-Provera / Meningioma Brain Tumors

Audience: Women who used Depo-Provera for a year or more and received a meningioma (brain tumor) diagnosis. Symptom-specific hook works well: headaches, vision changes, seizures following long-term use. This is a faster-growing tort in 2025-2026. CPL $150-400 range. Tone: calm and medical-credibility-forward. Cite the study, not speculation.

Roundup / Non-Hodgkin's Lymphoma

Audience: Farmers, landscapers, groundskeepers, agricultural workers, 40-65. Heavy exposure for 2+ years is the standard qualifier. The Bayer/Monsanto angle ("company knew") is well-established and credible - internal documents have been in public record since 2018. Platform: Meta is fine. CPL varies by geography.

Social Media Addiction / Teen Mental Health

Audience: Parents of teenagers 13-19 who show anxiety, depression, self-harm, or eating disorders following heavy platform use. Critical compliance note: Meta blocks these ads entirely because Meta is the defendant. Run exclusively on YouTube, TikTok, CTV, and programmatic. CPL: $18-60 depending on segment. Tone: righteous anger at corporations, not clinical language.

NEC Baby Formula (Premature Infants)

Audience: Parents of premature infants who developed necrotizing enterocolitis (NEC) after being fed cow's-milk-based hospital formula. Extremely specific injury. Emotional intensity is high - lead with validation, not urgency. No settlement dollar amounts, no graphic visuals. CPL $150-400. TCPA and first-party consent compliance are non-negotiable here - this audience has been through enough and any shady follow-up kills trust immediately.

Platform Selection by Case

• Meta (Facebook/Instagram): Best for 40+ demographics. Hair relaxer, AFFF, Depo-Provera, Roundup all run here. Social media addiction ads are blocked.
• YouTube: Long-form education for complex documentation-heavy torts. AFFF, Roundup, pharmaceutical cases.
• TikTok: Younger demographic only - social media addiction parents, some hair relaxer.
• CTV / Streaming: Pharmaceutical torts reaching 50+ demographics. Mass Tort Legal Group runs active CTV spots for GLP-1 / diabetic medication cases.

Compliance Checklist Before You Launch

Mass tort is one of the most regulated ad categories. One slip can mean account bans, FTC action, or bar complaints. Run this checklist before every creative goes live.

• Platform special category: Meta requires Health & Wellness Special Category for medical-adjacent campaigns since January 2025. Select it or your campaign may not deliver.
• No outcome guarantees: "Guaranteed settlement," "you will win," or specific dollar amounts are prohibited. "You may be entitled to compensation" is compliant. "You will receive $X" is not.
• No causation overstatement: "May be linked to" and "associated risk" are fine. "Definitely causes cancer" violates FTC substantiation rules and will get your creative flagged.
• Responsible attorney named: ABA Model Rule 7.2 requires at least one responsible lawyer or law firm named in every advertisement. A small on-screen text line at the close is sufficient.
• Disclosures on-screen: "Advertising material. Not legal advice. Past results do not guarantee future outcomes." Must be visible - not 4-point text, not hidden in a caption.
• No targeting of identified sick people: Meta policy prohibits implying the viewer has a health condition. "If you used [product] and received a [diagnosis]" is fine. "Because you have cancer" is flagged.
• First-party, named consent: Post-2024 FCC one-to-one consent rule. Your lead form must name the specific firm. Shared leads without individual consent per buyer are legally risky.
• TCPA compliance: Express written consent required before any outbound call or SMS. Do-Not-Call compliance is mandatory.
• Verify the science: Only advertise torts with live, active MDLs and peer-reviewed evidence. Zantac MDL was largely dismissed. Tylenol/autism faces adverse expert rulings. Advertising dead torts wastes budget and damages credibility.

Common Mistakes That Kill Mass Tort Campaigns

• Starting with the settlement amount. "Get up to $300,000!" leads with greed, not justice or validation. It attracts low-quality leads and triggers platform flags. Lead with the injury and the product instead.
• Too many cases at once. Running AFFF, hair relaxer, Roundup, and Depo-Provera in the same account at launch means four under-funded tests and no real data. Pick one case. Get your CPL dialed in. Then expand.
• Sending traffic direct to a lead form. Cold traffic that hits a raw form with no pre-lander education self-disqualifies at a much higher rate. The advertorial does the heavy lifting - it filters and warms the lead before the form.
• Soft callout hooks. "Have you or a loved one been injured?" is so overused it is ignored. Name the product. Name the injury. Name the timeframe. Specific hooks self-qualify your claimants.
• Optimizing for the wrong event. Post-January 2025 Meta rules: do not optimize toward Purchase for health-adjacent campaigns. Use Lead or Landing Page View. Purchase optimization on a medical-adjacent campaign is a fast path to account restriction.
• Slow lead follow-up. A lead called 5 minutes after submission converts 2-3x better than a lead called the next day. If your intake process is not near-instant, your CPR inflates regardless of how good the creative is.
• Skipping the responsible attorney disclosure. Running attorney advertising without naming a responsible lawyer violates ABA Model Rules in every US jurisdiction. It also makes the ad look like a scam, which hurts conversion.
• Using graphic injury imagery. Medical photos, visible tumors, surgical imagery - these trigger Meta enforcement fast. Illustrated diagrams or person-to-camera formats perform just as well and carry no image policy risk.

DIY vs. Outsource: When to Make Your Own Videos

You can shoot simple mass tort video ads yourself. Here is exactly how.

DIY method: Record a 60-second piece-to-camera. Plain background, decent lighting (ring light or window light). Use the script template above word-for-word with your case details filled in. Add on-screen text overlays for the hook, the evidence stat, and the compliance disclosure. Export at 1080p, 9:16 for Meta/TikTok, 16:9 for YouTube. Total time: 90 minutes per ad.

Where DIY works: Testing hooks on a $20/day budget. Validating an angle before committing to production. Low-competition torts where any video outperforms static images.

Where DIY breaks down: When you need multiple angles tested in parallel and you cannot shoot 5 variations in a week. When creative fatigue sets in and you need fresh variants every 10-14 days at scale. When a case hits a bellwether verdict and you need compliant creative live in 48 hours to capture the demand spike.